QCM
EW icon

Quest Capital Management’s Edwards Lifesciences EW Stock Holding History

Quest Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$843K Buy
6,510
+378
+6% +$44.1K 0.14% 98
2021
Q3 		$694K Buy
6,132
+127
+2% +$14.5K 0.14% 103
2021
Q2 		$622K Buy
6,005
+1,292
+27% +$122K 0.12% 111
2021
Q1 		$394K Buy
4,713
+94
+2% +$7.95K 0.08% 151
2020
Q4 		$421K Buy
4,619
+778
+20% +$64.5K 0.1% 128
2020
Q3 		$307K Buy
+3,841
New +$300K 0.08% 149

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quest Capital Management's EW Position: Q4 2021 in Review

Quest Capital Management increased its Edwards Lifesciences (EW) stake by 6.2% in Q4 2021, buying an estimated $44.1K and bringing the position to 6,510 shares worth $843K. The position accounts for 0.14% of the portfolio, ranked #98.

Quest Capital Management first reported a position in EW in Q3 2020 and has held it in 6 quarters since. 1,320 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • Quest Capital Management held 6,510 shares of Edwards Lifesciences worth $843K as of Q4 2021.
  • Quest Capital Management bought 378 Edwards Lifesciences shares in Q4 2021, an estimated $44.1K.
  • Edwards Lifesciences made up 0.14% of Quest Capital Management's portfolio in Q4 2021, its #98 holding.
  • Quest Capital Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 6 quarters since.
  • 1,320 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.